Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT02446405 |
Title | Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer |
Recruitment | Active, not recruiting |
Gender | male |
Phase | Phase III |
Variant Requirements | No |
Sponsors | University of Sydney |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | CAN |